Immunotherapy specific oral

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Hyposensitization; Hyposensitization oral; OIT; oral; oral immunotherapy; oral specific immunotherapy

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Method of specific immunotherapy with orally applied allergens in drop or tablet form. Good efficacy especially with children. This has been proven in several randomized and non-randomized studies, especially with cow's milk, chicken egg and peanut. S.a.u. SLIT (sublingual immunotherapy).

Remark: The phenomenon of oral immunotolerance has been known for decades. North American Indians have reported that they have been eating the leaves of poison sumac (Poison ivy) for a long time, thus preventing the otherwise massive contact allergies of the outer skin. According to Sampson, the intestinal epithelial cells play a significant role in the process of oral/enteric immunotolerance as "non-professsional" antigen-presenting cells. They mainly take up dissolved antigens and present their immune cells. A prerequisite for the development of an immunotolerance is an intact mucosal barrier. In contrast, immunization dominates in case of defects as well as local inflammations (Jäger L et al. (2001).

ImplementationThis section has been translated automatically.

For the initial treatment daily increase of the administered dose by 1 trp/day, regular increase of the concentration strength (bottle 1-4, or A-C). Afterwards, maintain the maintenance dose, application 3 times/week for 3 years.

Undesirable effectsThis section has been translated automatically.

ContraindicationThis section has been translated automatically.

Complication(s)This section has been translated automatically.

PreparationsThis section has been translated automatically.

Pangramine SLIT, TOL SL, GRAZAX

Note(s)This section has been translated automatically.

Alternatively, specific oral immunotherapy and sublingual immunotherapy ( SLIT) can be combined. After sublingual application in the mouth and defined absorption time, the allergen is swallowed.

In principle, the evidence is of low quality. Data on long-term effects are missing.

LiteratureThis section has been translated automatically.

  1. Bergmann KC (2003) Specific immunotherapy in allergic asthma. Pneumology 57: 84-90
  2. Bousquet J (1999) Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 54: 249-260
  3. Canonica GW, Passalacqua G (2003) Noninjection routes for immunotherapy. J Allergy Clin Immunol 111: 437-448
  4. Fuchs Th, Klimek L (2000) The allergen-specific immunotherapy (hyposensitization) part 2 Oral, sublingual and nasal application. HNO 48: 158-164
  5. Jäger L et al (2001) Food allergies and intolerances. Urban & Fischer Publishing House Munich, Jena S 24
  6. Morisset M et al (2007) Oral desensitization in children with milk and egg allergies obtains recovery ina
    significant proportion of cases. A randomized study in 60 children with cow's milk allergy and 90 children with egg allergy. Eur Ann Allergy Clin Immunol 39:12-19.
  7. Mortemousque B et al (2003) House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy 33: 464-469
  8. Nelson HS (2003) Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 111(3 Suppl): 793-798
  9. Passalacqua G et al (1998) Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 351: 629-632
  10. Varshney P et al (2011) A randomized controlled study of peanut oral immunotherapy: clinicaldesensitization
    and modulation of the allergic response. J Allergy Clin Immunol 127:654-660.
  11. Vazquez-Ortiz M et al (2014) Baseline specific IgE levels are useful to predict safety of oral immunotherapy
    in egg-allergic children. Clin Exp Allergy 44:130-141.
  12. Woodfolk JA, Platts-Mills TA (2002) The immune response to intrinsic and extrinsic allergens: determinants of allergic disease. Int Arch Allergy Immunol 129: 277-285

Authors

Last updated on: 29.10.2020